GlobeNewswire

QUANTRO Therapeutics secures key Austrian research grant to build its AI-powered drug discovery platform
03/11/2026
Austrian Research Promotion Agency FFG awards funding to QUANTRO to develop and implement ASCEND, an integrated artificial intelligence platform for transcription factor drug discovery Vienna, Austria, Nov. 03, 2026 ( [...]
BridgeBio to Present New Acoramidis Data on Heart Failure Events in ATTR-CM at the American Heart Association Scientific Sessions 2026
03/11/2026
PALO ALTO, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) ("BridgeBio" or the "Company"), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for [...]
Helus Pharma to Participate in the Guggenheim Healthcare Innovation Conference
03/11/2026
CEO Michael Halstead to participate in a fireside chat on November 9, 2026 at 3:00 p.m. EDT NEW YORK and TORONTO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Helus Pharma Inc. (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or “ [...]
ARCHIMED Life Science Tools & Services Completes Acquisition of Standard BioTools’ Microfluidics Business, Now Biomark Scientific
03/11/2026
Business will operate as Biomark Scientific, a leader in accessible, scalable and automated genomic workflows powered by proprietary microfluidics technology BOSTON, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Global [...]
Ascentage Pharma to Participate in Two Upcoming Investor Conferences in London
03/11/2026
ROCKVILLE, Md., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company [...]
Palvella Therapeutics to Participate in the Stifel 2026 Healthcare Conference
03/11/2026
WAYNE, Pa., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (Palvella or the “Company”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies [...]
Beta Bionics Announces Participation at Upcoming Investor Conferences
03/11/2026
IRVINE, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will participate at [...]
Decoy Therapeutics Provides Third Quarter 2026 Business Update
03/11/2026
Lead pan-coronavirus program expected to file CTA/IND in 2H 2027 Optimized lead candidate shows potential for once-weekly dosing in preclinical studies Cash on balance sheet of $8.1 million at September 30, 2026 [...]
Kailera Therapeutics to Participate in November Investor Conferences
03/11/2026
WALTHAM, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc. (Nasdaq: KLRA) (Kailera), a clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced that Ron [...]
Why Fat Transfer Breast Enlargement Is Trending in Dubai
03/11/2026
DUBAI, United Arab Emirates, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Fat transfer breast enlargement in Dubai is becoming increasingly popular among individuals seeking to increase their breast size while retaining a natural [...]
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/11/2026
NEW HAVEN, Conn., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that on November 1, 2026, Invivyd granted seven newly hired non-executive employees options to purchase an aggregate of [...]
Maze Therapeutics to Participate in Upcoming Investor Conferences
03/11/2026
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney [...]
Anavex Life Sciences Names Terrie Kellmeyer, Ph.D., as President and Chief Executive Officer and Member of the Board of Directors
03/11/2026
Seasoned biopharmaceutical executive with more than 30 years of leadership experience spanning clinical development, regulatory strategy and operational execution appointed to lead company into new phase of clinical [...]
Cardiff Oncology to Participate in the UBS Global Biopharma Conference
03/11/2026
SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced [...]
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
03/11/2026
ALACHUA, Fla. and TAMPA, Fla., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, [...]
Human Appeal Receives Canadian Parliamentary Delegation to Rare Hospital in Northwest Syria
03/11/2026
MISSISSAUGA, Ontario, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Human Appeal Canada welcomed a Canadian Parliamentary and Humanitarian Delegation to Syria, which included a visit to Al-Iman Hospital in Sarmada , where a baby [...]
Upgrade of revenue and operating profit guidance
03/11/2026
ANNOUNCEMENT NO. 324 3 November 2026 ChemoMetec maintained its positive momentum in the months of the 2026/27 financial year, supported by higher-than-expected demand for our instruments, with the NC-203 being a key [...]
Transactions in connection with share buy-back program
03/11/2026
Company announcement no. 44 - 26 03 November 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company [...]
Global Pharmaceutical Company Commits to a Dual-Site Deal with AGC Biologics Exceeding €0.5 Billion
03/11/2026
Agreement builds on customer’s long-term deal in new Yokohama facility for five commercial biologics programs, now allocating an additional six commercial programs to Copenhagen facility to consolidate high-volume, [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum